CClinicalTrials.gg
CompletedNCT03787342Updated Jul 22, 2020

Comparison of Double-Flap Incision, Modified Periosteal Releasing Incision, and Coronally Advanced Lingual Flap to Periosteal Releasing Incision for Flap Advancement

An interventional study of Double Flap Incision and Modified Periosteal Releasing Incision in Flap Advancement, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-07-22.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Dec 2016, registered Jul 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
All
01

Study summary

Guided Bone Regeneration (GBR) is a reliable method to augment insufficient bone volume for implant placement. Membrane exposure is a major complication which is avoided by tension free primary closure. Classically Periosteal Releasing Incision (PRI) is performed to advance the flap. The aim of this trial is to compare Double Flap Incision (DFI), Modified Periosteal Releasing Incision (MPRI) \& Coronally Advanced Lingual Flap (CALF) to PRI in terms of flap advancement, postoperative pain \& swelling, membrane exposure and the amount of bone gain clinically and radiographically in GBR procedures.

Read the detailed description

Study setting:

The patients will be assigned from the outpatient clinic of "The Faculty of Oral and Dental Medicine, Cairo University". Surgical procedures will be held in the periodontology clinic of the faculty. The recruited sample would be from the Egyptian urban and rural population.

Eligibility Criteria:

Inclusion criteria:

  1. Partially edentulous patients in the mandibular posterior region.
  2. Patients with healthy systemic condition.
  3. Insufficient ridge width (\< 5mm).
  4. Presence of proper inter-arch space for placement of the implant prosthetic part.
  5. Adequate soft tissue biotype (≥ 2mm).
  6. No clinical evidence of active periodontal disease or oral infections.

Exclusion Criteria:

  1. Patients with systemic conditions that may interfere with the results of the study.
  2. Patients with local pathological defects related to the area of interest.
  3. Unmotivated, uncooperative patients with poor oral hygiene.
  4. Patients with habits that may jeopardize the implant longevity and affect the results of the study such as smoking, alcoholism or para-functional habits.
  5. History of bone associated diseases or medication affecting bone metabolism e.g.; bisphosphonate treatment.
  6. History of radiation therapy in the head or neck region.
  7. Current anti-tumor chemotherapy.
  8. Pregnancy.
  9. Inflammatory and autoimmune diseases of the oral cavity.

Interventions:

Pre-surgical phase:

  1. Medical History Questionnaire (MHQ): Patients will be interviewed to gather information regarding general and oral health and MHQ will be filled by the patient and will be kept among patient's record file.
  2. Clinical intra-oral examination

    • To ensure that the patient fulfills the previously mentioned defect-inclusion criteria.
    • Thorough intra-oral examination including teeth for caries, fracture, missing, or hopeless teeth and gingival-mucosal tissues for gingivitis, periodontitis, or oral lesions.
    • Referral for consultation or treatment if needed before the surgical phase.
  3. If the patient meets the clinical selection criteria then radiographic examination will be held. CBCT will be performed for adequate evaluation of bone width and density and to be kept as a record for postoperative comparison.
  4. Patients must sign an informed consent to clinical research previously approved by the Faculty of Oral and Dental Medicine, Cairo University.
  5. Eligible patients will be randomized before being enrolled in the study.

Surgical phase:

The patients will be assigned into four groups, all undergoing GBR using Ti- mesh and Xenograft as follow:

  • Group A: Flap advancement will be achieved using the DFI and this group will be assigned as a test group.
  • Group B: Flap advancement will be achieved using the MPRI and this group will be assigned as a test group.
  • Group C: Flap advancement will be achieved using the CALF and this group will be assigned as a test group.
  • Group D: Flap advancement will be achieved using the PRI and this group will be assigned as the control group.

Surgical Protocol:

The surgical procedures will be performed under local anesthesia

Group A:

A full-thickness crestal incision will be made over the edentulous ridge, and then one partial-thickness vertical incision will be made on the buccal side. A partial-thickness flap will be raised first to separate the mucosal layer from the overlying periosteum. Subsequently, the periosteal layer will be elevated to expose the underlying alveolar process. Xenograft and Ti-mesh will be used to augment the defective site then periosteal flap will be sutured first, with periosteal sutures securing the regenerative site. Then the mucosal flap will be closed.

Group B:

A full-thickness muco-periosteal flap is reflected on the buccal side (crestal incision and two vertical releasing incisions). Near the base of mucoperiosteal flap, the periosteum is incised less than 0.5mm in depth, creating two segments, "coronal segment" and "apical segment," of the periosteal flap. The shallow incision helps in preventing damage to the submucosal layer. The flap is pulled with a pair of periodontal forceps laterally. Subsequently, the "lateral stretching" of the coronal segment of the flap is performed by applying pressure using the blunt face of scalpel blade with sweeping motion. This motion helps stretching the flap over the submucosa, thereby permitting the flap to be mobile and thus facilitates flap advancement (approximately 3-5mm). Xenograft and Ti-mesh will be used to augment the defective site.

Group C:

A full-thickness crestal incision will be performed in the keratinized tissue from the distal surface of the more distal tooth to the retromolar pad. The flap design will be continued intrasulcularly on both vestibular and lingual sides of the mesial portion of the flap, buccally, it will be finished with a vertical releasing incision. On the lingual side, a full-thickness mucoperiosteal flap will be elevated until reaching the mylohyoid line. Then, using a blunt instrument it will be localized a connective tissue band continuing with the epimysium of the mylohyoid muscle. The blunt instrument will be inserted below this connective band, and, with gentle traction in the coronal direction, this muscular insertion will be detached from the lingual flap.

Group D:

A full-thickness crestal incision will be made over the edentulous ridge followed by one full-thickness vertical incision on the buccal side and a full thickness flap will be raised. Xenograft and Ti-mesh will be used to augment the defective site then incremental incisions of 1-3 mm into the periosteum and submucosa will be used to advance the muco-periosteal flap. The flap will then be sutured as a whole unit.

Post-surgical instructions:

  • 1 g of Amoxicilin twice a day for 6 days with analgesic and anti-inflammatory drug, every 8 hours for 4 to 5 days, and 0.2% chlorexidine rinse 1min three times a day for 2 weeks, starting the day after surgery.
  • Immediately after surgery, ice packs will be applied onto the treated area and it is recommended that they be kept in place for at least 4 h.
  • Avoid tooth brushing especially at surgical sites, and soft diet to avoid trauma to the site of surgery for the first 3 weeks.
  • Subsequent visits will be scheduled for healing assessment and measurement recording and if necessary, a professional supra-gingival prophylaxis will be performed.
  • Sutures were removed after 2 week.
  • A removable prosthesis was never allowed, during healing, to avoid trans-mucosal pressure on the operated area.
02

Conditions studied

  • Flap Advancement

Browse trials for

Keywords

  • Periosteal Releasing Incision, Modified Periosteal Releasing Incision, Coronally Advanced Lingual Flap, Double Flap Incision, Titanium mesh, GBR
03

In context

Surgical Wound

519 studies on the registry are indexed under Surgical Wound; 71 are open to participants now.

This study's enrollment of 38 is below the median of 80 across 412 interventional studies indexed under Surgical Wound.

Browse Surgical Wound studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Partially edentulous patients in the mandibular posterior region.
  2. Patients with healthy systemic condition.
  3. Insufficient ridge width (\< 5mm).
  4. Presence of proper inter-arch space for placement of the implant prosthetic part.
  5. Adequate soft tissue biotype (≥ 2mm).
  6. No clinical evidence of active periodontal disease or oral infections.

Exclusion criteria

Exclusion Criteria:

  1. Patients with systemic conditions that may interfere with the results of the study.
  2. Patients with local pathological defects related to the area of interest.
  3. Unmotivated, uncooperative patients with poor oral hygiene.
  4. Patients with habits that may jeopardize the implant longevity and affect the results of the study such as smoking, alcoholism or para-functional habits.
  5. History of bone associated diseases or medication affecting bone metabolism e.g.; bisphosphonate treatment.
  6. History of radiation therapy in the head or neck region.
  7. Current anti-tumor chemotherapy.
  8. Pregnancy.
  9. Inflammatory and autoimmune diseases of the oral cavity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    DFI "Double Flap Incision"

    A full-thickness crestal incision will be made over the edentulous ridge, and then one partial-thickness vertical incision will be made on the buccal side. A partial-thickness flap will be raised first to separate the mucosal layer from the overlying periosteum. Subsequently, the periosteal layer will be elevated to expose the underlying alveolar process. Xenograft and Ti-mesh will be used to augment the defective site then periosteal flap will be sutured first, with periosteal sutures securing the regenerative site. Then the mucosal flap will be closed.

    Procedure: Double Flap Incision

  • Experimental
    MPRI "Modified PRI"

    A full-thickness muco-periosteal flap is reflected on the buccal side (crestal incision and two vertical releasing incisions). Near the base of mucoperiosteal flap, the periosteum is incised less than 0.5mm in depth, creating two segments, "coronal segment" and "apical segment," of the periosteal flap. The shallow incision helps in preventing damage to the submucosal layer. The flap is pulled with a pair of periodontal forceps laterally. Subsequently, the "lateral stretching" of the coronal segment of the flap is performed by applying pressure using the blunt face of scalpel blade with sweeping motion to allow flap advancement.

    Procedure: Modified Periosteal Releasing Incision

  • Experimental
    CALF "Coronally Advanced Lingual Flap"

    A full-thickness crestal incision will be performed in the keratinized tissue from the distal surface of the more distal tooth to the retromolar pad. The flap design will be continued intrasulcularly on both vestibular and lingual sides of the mesial portion of the flap, buccally, it will be finished with a vertical releasing incision. On the lingual side, a full-thickness mucoperiosteal flap will be elevated until reaching the mylohyoid line. Then, using a blunt instrument it will be localized a connective tissue band continuing with the epimysium of the mylohyoid muscle. The blunt instrument will be inserted below this connective band, and, with gentle traction in the coronal direction, this muscular insertion will be detached from the lingual flap.

    Procedure: Coronally Advanced Lingual Flap

  • Active comparator
    PRI "Periosteal Releasing Incision"

    A full-thickness crestal incision will be made over the edentulous ridge followed by one full-thickness vertical incision on the buccal side and a full thickness flap will be raised. Xenograft and Ti-mesh will be used to augment the defective site then incremental incisions of 1-3 mm into the periosteum and submucosa will be used to advance the muco-periosteal flap. The flap will then be sutured as a whole unit.

    Procedure: Periosteal releasing incision

Interventions

  • ProcedureDouble Flap Incision

    A full-thickness crestal incision will be made over the edentulous ridge, and then one partial-thickness vertical incision will be made on the buccal side. A partial-thickness flap will be raised first to separate the mucosal layer from the overlying periosteum. Subsequently, the periosteal layer will be elevated to expose the underlying alveolar process. Xenograft and Ti-mesh will be used to augment the defective site then periosteal flap will be sutured first, with periosteal sutures securing the regenerative site. Then the mucosal flap will be closed.

    Also known as: DFI

  • ProcedureModified Periosteal Releasing Incision

    A full-thickness muco-periosteal flap is reflected on the buccal side (crestal incision and two vertical releasing incisions). Near the base of mucoperiosteal flap, the periosteum is incised less than 0.5mm in depth, creating two segments, "coronal segment" and "apical segment," of the periosteal flap. The shallow incision helps in preventing damage to the submucosal layer. The flap is pulled with a pair of periodontal forceps laterally. Subsequently, the "lateral stretching" of the coronal segment of the flap is performed by applying pressure using the blunt face of scalpel blade with sweeping motion to allow flap advancement.

    Also known as: MPRI

  • ProcedureCoronally Advanced Lingual Flap

    A full-thickness crestal incision will be performed in the keratinized tissue from the distal surface of the more distal tooth to the retromolar pad. The flap design will be continued intrasulcularly on both vestibular and lingual sides of the mesial portion of the flap, buccally, it will be finished with a vertical releasing incision. On the lingual side, a full-thickness mucoperiosteal flap will be elevated until reaching the mylohyoid line. Then, using a blunt instrument it will be localized a connective tissue band continuing with the epimysium of the mylohyoid muscle. The blunt instrument will be inserted below this connective band, and, with gentle traction in the coronal direction, this muscular insertion will be detached from the lingual flap.

    Also known as: CALF

  • ProcedurePeriosteal releasing incision
06

What researchers measure

Primary outcomes

  1. Flap advancement

    Flap advancement in millimeters will be measured as the difference before and after Double flap Incision, Modified Periosteal Releasing Incision, Coronally Advanced Lingual Flap, and Periosteal Releasing Incision in millimeters using periodontal probe.

    Time frame: Intraoperative

Secondary outcomes

  1. Postoperative Pain

    Pain will be recorded using Numerical Rating scale (NRS). It is a scale from 0 to 10. 0 indicates no pain and 10 indicates severe pain.

    Time frame: 7 days postoperatively

  2. Postoperative Swelling

    will be recorded using Visual Analogue Scale (VAS). It is a scale from 0 to 4. 0 indicates no swelling while 4 indicates severe extra-oral swelling.

    Time frame: 7 days postoperatively

Other outcomes

  1. Postoperative membrane exposure

    Measure the dimensions of the exposure using a periodontal probe in millimeters.

    Time frame: will be evaluated at 1, 2, 3, 4, 12, 24 weeks postoperative

  2. Bone width gain

    The amount of bone gain will be measured before and after in millimeters on a cone beam CT \& Clinically using bone caliper.

    Time frame: preoperative & 6 months postoperative.

07

Study locations

1 site
  • Cairo University
    Cairo, 12613, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03787342
Lead sponsor
Cairo University
Responsible party
Nada Zazou (Principle Investigator, assistant Lecturer, Modern Sciences and Arts University (MSA)., Cairo University) — Principal investigator
First posted
Dec 26, 2018
Start date
Dec 1, 2016
Primary completion
Aug 30, 2019
Completion
Sep 30, 2019
Last update
Jul 22, 2020

Study contacts

Nada Zazou, Masters
principal investigator · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion